Protocol Information

If you are interested in learning more about this study, please call or email the contact person below

Title GLP-Receptor Agonist Therapy and Albuminuria in Patients with Type 2 Diabetes
Description The study visits will be at Erie County Medical Center in Buffalo

If you are interested in the study please contact the coordinator below.
Objective The purpose of this research is to evaluate the effects of Exenatide extended release treatment for 1 year on albuminuria (protein in urine) levels in type 2 diabetes patients.

Keywords: albuminuria, type II diabetes
Principal Investigator DANDONA, PARESH
Age Group Adult
Drugs Involved
Clinical Trials.gov http://www.clinicaltrials.gov/ct2/show/NCT03029351/
Status Open
Key Eligibility albuminuria (protein in urine)

type 2 diabetes
Disease Group Diabetes; Endocrine Diseases
Treatment Exenatide
Contact MEGHAN KIRSCH
716-898-1950
meghanki@buffalo.edu